Search - Université de Rennes Access content directly

Filter your results

8 Results
Author: personID (integer) : 772312

Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC

Loic Ysebaert , Roch Houot , Ibrahim Yakoub-Agha , Franck Morschhauser , Charles Herbaux et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles hal-01290424v1

Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.

Emilie Reboursiere , Fabien Le Bras , Charles Herbaux , Emmanuel Gyan , Aline Clavert et al.
Oncotarget, 2016, 7 (51), pp.85573-85583. ⟨10.18632/oncotarget.10764⟩
Journal articles hal-01475957v1
Image document

Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation

Guillaume Manson , Jean-Baptiste Mear , Charles Herbaux , Jean-Marc Schiano , Olivier Casasnovas et al.
European Journal of Cancer, 2019, 115, pp.47-56. ⟨10.1016/j.ejca.2019.04.006⟩
Journal articles hal-02134578v1
Image document

Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)

Guillaume Manson , Charles Herbaux , Jean Marc Schiano de Colella , René-Olivier Casasnovas , Aspasia Stamatoullas et al.
British Journal of Haematology, 2022, 198 (1), pp.203-206. ⟨10.1111/bjh.18198⟩
Journal articles hal-03665134v1

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma Real World Evidence from the French Early Access Program

Roch Houot , Guillaume Manson , Jean-Baptiste Mear , Charles Herbaux , Jean Marc Schiano de Collela et al.
Blood, 2018, 132 (1), pp.1638. ⟨10.1182/blood-2018-99-110960⟩
Journal articles hal-02076926v1
Image document

Prolonged remissions after anti-PD1 discontinuation in patients with Hodgkin lymphoma

Guillaume Manson , Charles Herbaux , Pauline Brice , Krimo Bouabdallah , Aspasia Stamatoullas et al.
Blood, 2018, 131 (25), pp.2856-2859. ⟨10.1182/blood-2018-03-841262⟩
Journal articles hal-01812478v1
Image document

Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma

John Timmerman , Charles Herbaux , Vincent Ribrag , Andrew D. Zelenetz , Roch Houot et al.
American Journal of Hematology, 2020, 95 (5), pp.510-520. ⟨10.1002/ajh.25757⟩
Journal articles hal-02798009v1
Image document

Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation

Guillaume Manson , Pauline Brice , Charles Herbaux , Kamal Bouabdallah , Chloé Antier et al.
Haematologica, 2020, 105 (11), pp.2664-2666. ⟨10.3324/haematol.2019.242529⟩
Journal articles hal-02485796v1